3.0
Feb 29, 2016
Recommend
CEO approval
Business Outlook
Pros
Great benefits in line with other pharma companies; smart, innovative people (not including management)
Cons
Unclear company direction, consistent lay-offs, not willing to accept the main drug isn't meant to be a blockbuster. High expectations for sales that are unattainable.